Hydroxyquinoline vaginal and Insulin Degludec (U-100) Vials
Determining the interaction of Hydroxyquinoline vaginal and Insulin Degludec (U-100) Vials and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: hydroxyquinoline topical
Brand name: Trimo-San
Synonyms: Hydroxyquinoline (vaginal)
Generic Name: insulin degludec
Brand name: Tresiba, Tresiba FlexTouch
Synonyms: Insulin degludec, Insulin Degludec
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Hydroxyquinoline vaginal-Insulin Degludec (U-200) Prefilled Pens
- Hydroxyquinoline vaginal-Insulin degludec and liraglutide
- Hydroxyquinoline vaginal-Insulin degludec and liraglutide Subcutaneous
- Hydroxyquinoline vaginal-Insulin degludec Subcutaneous
- Hydroxyquinoline vaginal-Insulin detemir
- Hydroxyquinoline vaginal-Insulin Detemir (Cartridges and Prefilled Syringes)
- Insulin Degludec (U-100) Vials-Hydroxyurea
- Insulin Degludec (U-100) Vials-Hydroxyurea Capsules 200 mg, 300 mg, 400 mg
- Insulin Degludec (U-100) Vials-Hydroxyurea Capsules 500 mg
- Insulin Degludec (U-100) Vials-Hydroxyurea Tablets
- Insulin Degludec (U-100) Vials-Hydroxyzine
- Insulin Degludec (U-100) Vials-Hydroxyzine Capsules